ARCHIVES

Memorial’s Scher Warns FDA About Flaws In Provenge Data, Urges Not To Approve.

This article is from The Cancer Letter archive.

Vol. 33 No. 14 | April 13, 2007

Download PDF Visit The Full Archive

Related Articles

1991 Bypass Budget Would Fund 50 Percent Of Competing Grants

May 26, 1989

AACR honors Five With Awards Next Month

April 2, 1993

Trial Data: No Benefit In Adding Perifosine to Capecitabine

June 29, 2012

DCPC Bard Approves Concepts For New Grant Programs

November 13, 1992

NCAB working Group Is Not Subject To Open Meetings Law, NCI Official Says

December 9, 1994

CCOP Review Competed, Enough Good Applications In Funding Range To Get Viable Program Started

February 18, 1983